MYD88 and cancer: Based on the findings, it is recommended that a targeted delivery of the TLR3 ligand to the endosomal compartment, bypassing the MyD88 signaling and subsequently causing activation of the TRIF signaling, can trigger the apoptotic cascade in cancer cells.